DE19975013I1 - 2.Oxo-Imidazolidin-Verbindungen Verfahren zu derenHerstellung und pharmazeutische Zusammensetzung - Google Patents

2.Oxo-Imidazolidin-Verbindungen Verfahren zu derenHerstellung und pharmazeutische Zusammensetzung

Info

Publication number
DE19975013I1
DE19975013I1 DE1999175013 DE19975013C DE19975013I1 DE 19975013 I1 DE19975013 I1 DE 19975013I1 DE 1999175013 DE1999175013 DE 1999175013 DE 19975013 C DE19975013 C DE 19975013C DE 19975013 I1 DE19975013 I1 DE 19975013I1
Authority
DE
Germany
Prior art keywords
oxo
preparation
pharmaceutical composition
compounds process
imidazolidine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1999175013
Other languages
English (en)
Inventor
Naoto Yoneda
Jyoji Kato
Kimiaki Hayashi
Takashi Ochiai
Keizo Kinashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of DE19975013I1 publication Critical patent/DE19975013I1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE1999175013 1982-05-24 1983-05-20 2.Oxo-Imidazolidin-Verbindungen Verfahren zu derenHerstellung und pharmazeutische Zusammensetzung Pending DE19975013I1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57088637A JPS6058233B2 (ja) 1982-05-24 1982-05-24 ２−オキソイミダゾリジン誘導体及びその製法

Publications (1)

Publication Number Publication Date
DE19975013I1 true DE19975013I1 (de) 2003-09-04

Family

ID=13948325

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1999175013 Pending DE19975013I1 (de) 1982-05-24 1983-05-20 2.Oxo-Imidazolidin-Verbindungen Verfahren zu derenHerstellung und pharmazeutische Zusammensetzung
DE8383105024T Expired DE3373100D1 (en) 1982-05-24 1983-05-20 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8383105024T Expired DE3373100D1 (en) 1982-05-24 1983-05-20 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition

Country Status (8)

Country Link
US (1) US4508727A (de)
EP (1) EP0095163B1 (de)
JP (1) JPS6058233B2 (de)
DE (2) DE19975013I1 (de)
ES (2) ES522678A0 (de)
HK (1) HK32689A (de)
MY (1) MY100095A (de)
SG (1) SG5989G (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61293538A (ja) * 1985-06-24 1986-12-24 Shinto Paint Co Ltd 固体または半固体溶質の溶媒による溶解方法
KR930004646B1 (ko) * 1986-12-09 1993-06-02 다나베 세이야꾸 가부시끼가이샤 심기능 부전의 예방 및 치료제
ATE81465T1 (de) * 1986-12-12 1992-10-15 Tanabe Seiyaku Co Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
JPH066833Y2 (ja) * 1988-05-17 1994-02-23 川澄化学工業株式会社 輸液バッグ
JPH0645603B2 (ja) * 1988-12-16 1994-06-15 田辺製薬株式会社 光学活性２‐オキソイミダゾリジン誘導体の製法
JPH07121916B2 (ja) * 1993-12-10 1995-12-25 田辺製薬株式会社 光学活性３−アシル−２−オキソイミダゾリジン−４−カルボン酸誘導体及びその製法
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
JP4780437B2 (ja) * 2004-12-08 2011-09-28 大原薬品工業株式会社 ２−オキソイミダゾリジン誘導体の製造方法
JP4799085B2 (ja) * 2005-09-02 2011-10-19 株式会社カネカ 光学活性ｎ置換アミノアシル環状尿素誘導体の製造法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (de) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf-erkrankungen
JP5206926B2 (ja) * 2007-07-30 2013-06-12 株式会社Ｄｎｐファインケミカル宇都宮 塩酸イミダプリルの製造方法
AU2012303683B2 (en) 2011-08-26 2016-09-08 Wockhardt Limited Methods for treating cardiovascular disorders
EP2986599A1 (de) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen
CN104119424B (zh) * 2014-07-01 2018-12-18 上海天慈生物谷生物工程有限公司 (4s)-3-[(2s)-2[(1s)-1-乙氧羰基-3-苯丙基]氨基丙酰基]-1-甲基-2-氧代咪唑啉-4-羧酸的制备方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN105713068B (zh) * 2014-12-04 2021-04-20 湖南九典制药股份有限公司 一种制备咪达普利关键中间体及其衍生物的方法
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
EP0048159A3 (de) * 1980-09-17 1982-05-12 University Of Miami Carboxyalkyl-Peptide und Thioäther und Äther von Peptiden als antihypertensive Mittel
US4296110A (en) * 1980-10-28 1981-10-20 E. I. Du Pont De Nemours And Company Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
JPS5835114A (ja) * 1981-08-21 1983-03-01 ザ・ユニバ−シイテイ・オブ・マイアミ 抗高血圧剤

Also Published As

Publication number Publication date
EP0095163B1 (de) 1987-08-19
ES8603427A1 (es) 1985-12-16
ES535980A0 (es) 1985-12-16
MY100095A (en) 1989-10-10
DE3373100D1 (en) 1987-09-24
EP0095163A3 (en) 1984-09-12
ES8503667A1 (es) 1985-03-16
ES522678A0 (es) 1985-03-16
HK32689A (en) 1989-04-28
EP0095163A2 (de) 1983-11-30
SG5989G (en) 1989-06-09
JPS58203971A (ja) 1983-11-28
JPS6058233B2 (ja) 1985-12-19
US4508727A (en) 1985-04-02

Similar Documents

Publication Publication Date Title
DE19975013I1 (de) 2.Oxo-Imidazolidin-Verbindungen Verfahren zu derenHerstellung und pharmazeutische Zusammensetzung
ATE46900T1 (de) Phenylethanolaminotetraline, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
PT77488B (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
IT1130184B (it) Composti 2 penem,metodo per la loro preparazione e composizioni farmaceutiche contenenti tali composti
ATE66224T1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE19975037I2 (de) 3H-Imidazo-5,1-d-1,2,3,5-tetrazin-4-on-Derivate Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
ATE10094T1 (de) 3,4-bis-substituierte 1,2,5-oxadiazol-2-oxide, verfahren zu ihrer herstellung, und sie enthaltende pharmazeutische zubereitungen.
IL68680A (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2-analogues,process for their preparation and pharmaceutical compositions containing them
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE2862122D1 (en) 1,4-benzodiazepines and their salts, process for their preparation and pharmaceutical compositions containing them
PT78487B (de) 4-phenyl-tetrahydro-furano-pyridine verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
DE3067174D1 (en) Tetrahydro-fluorene compounds, processes for their preparation and pharmaceutical compositions thereof
PT68656A (de) Neue 4-phenyl-thieno-/2,3-c/-piperidine verfahren zu ihrerherstellung und diese enthaltende pharmazeutische zusammensetzungen
PT75626A (de) Aminooxazolylverbindungen verfahren zu ihrer herstellung pharmazeutische praeparate welche diese verbindungen enthalten
DE3372968D1 (en) Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use
ATE3425T1 (de) Hypoglykaemische guanylamidine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT81078B (de) Aminosaeurederivate verfahren zu ihrer herstellung und pharmazeutische zusamensetzungen
LU84492A1 (de) Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate
ATE29663T1 (de) Kombinierte pharmazeutische zusammensetzung und zugehoeriges verfahren.
GB2080300B (en) Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them
GB2080301B (en) Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them
DE59005327D1 (de) Substituierte Tetrachalkogenfulvalene und Verfahren zu deren Herstellung.